Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer.
第一作者:
Kejun,Liu
第一单位:
Department of Oncology, Dongguan Institute for Clinical Cancer Research, Dongguan People's Hospital, Southern Medical University, 3 Wandao Road South, Dongguan, 523059, Guangdong, China.
作者:
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药(Antineoplastic Agents);脑肿瘤(Brain Neoplasms);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);女(雌)性(Female);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);分子靶向治疗(Molecular Targeted Therapy);突变(Mutation);预后(Prognosis);蛋白激酶抑制剂(Protein Kinase Inhibitors);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome)
DOI
10.1186/s12885-020-6543-y
PMID
32000711
发布时间
2020-09-28
- 浏览4
BMC cancer
76页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



